Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10017759 was granted and assigned to Illumina on July, 2018 by the United States Patent and Trademark Office. | 10017759 | July 10, 2018 | |||||||
Patent 11682195 was granted and assigned to NantOmics on June, 2023 by the United States Patent and Trademark Office. | 11682195 | June 20, 2023 | |||||||
Patent 9850536 was granted and assigned to Illumina on December, 2017 by the United States Patent and Trademark Office. | 9850536 | December 26, 2017 | |||||||
Patent 10041127 was granted and assigned to Guardant Health on August, 2018 by the United States Patent and Trademark Office. | 10041127 | August 7, 2018 | |||||||
Patent 11648561 was granted and assigned to NeuMoDx Molecular on May, 2023 by the United States Patent and Trademark Office. | 11648561 | May 16, 2023 | |||||||
Patent 9587273 was granted and assigned to Illumina on March, 2017 by the United States Patent and Trademark Office. | 9587273 | March 7, 2017 | |||||||
Patent 10538759 was granted and assigned to Illumina on January, 2020 by the United States Patent and Trademark Office. | 10538759 | January 21, 2020 | |||||||
Patent 9598731 was granted and assigned to Guardant Health on March, 2017 by the United States Patent and Trademark Office. | 9598731 | March 21, 2017 | |||||||
Patent 10395772 was granted and assigned to Tempus Labs (company) on August, 2019 by the United States Patent and Trademark Office. | 10395772 | August 27, 2019 | |||||||
Patent 8951781 was granted and assigned to Illumina on February, 2015 by the United States Patent and Trademark Office. | 8951781 | February 10, 2015 | |||||||
Patent 11935152 was granted and assigned to Tempus Labs (company) on March, 2024 by the United States Patent and Trademark Office. | 11935152 | March 19, 2024 | |||||||
Patent 11543352 was granted and assigned to Illumina on January, 2023 by the United States Patent and Trademark Office. | 11543352 | January 3, 2023 | |||||||
11434523 | September 6, 2022 | ||||||||
11364504 | June 21, 2022 | ||||||||
Patent 10423861 was granted and assigned to Illumina on September, 2019 by the United States Patent and Trademark Office. | 10423861 | September 24, 2019 | |||||||
Patent 7914988 was granted and assigned to Illumina on March, 2011 by the United States Patent and Trademark Office. | 7914988 | March 29, 2011 | |||||||
Patent 10119167 was granted and assigned to Illumina on November, 2018 by the United States Patent and Trademark Office. | 10119167 | November 6, 2018 | |||||||
Patent 7535936 was granted and assigned to Daylight Solutions on May, 2009 by the United States Patent and Trademark Office. | 7535936 | May 19, 2009 | |||||||
11385162 | July 12, 2022 | ||||||||
Patent 11675175 was granted and assigned to Illumina on June, 2023 by the United States Patent and Trademark Office. | 11675175 | June 13, 2023 | |||||||
Patent 11908548 was granted and assigned to Illumina on February, 2024 by the United States Patent and Trademark Office. | 11908548 | February 20, 2024 | |||||||
Patent 11361194 was granted and assigned to Illumina on June, 2022 by the United States Patent and Trademark Office. | 11361194 | June 14, 2022 | |||||||
Patent 11347965 was granted and assigned to Illumina on May, 2022 by the United States Patent and Trademark Office. | 11347965 | May 31, 2022 | |||||||
Patent 11294177 was granted and assigned to Nippon Kayaku on April, 2022 by the United States Patent and Trademark Office. | 11294177 | April 5, 2022 | |||||||
Patent 9512422 was granted and assigned to Illumina on December, 2016 by the United States Patent and Trademark Office. | 9512422 | December 6, 2016 |